Votrient
(Pazopanib)
(400 mg)
(thirty)
(Tablets)
Votrient (pazopanib) 400 mg 30 tab. Glaxo United Kingdom
Article:
Indications
- Treatment of locally advanced and/or metastatic renal cell carcinoma (RCC).
- Treatment of patients with advanced soft tissue sarcoma previously treated with chemotherapy, except for patients with gastrointestinal stromal tumor or liposarcoma.sham
-
Commercial name:Votrient
-
Сhemical name:Pazopanib
-
Dosage:400 mg
-
Quantity:thirty
-
Release form:Tablets
-
Производитель:Novartis
No reviews yet